Evidence map›Paper›PMID 30010001›Full record

ArticleNeurobiology of disease2018

D159 and S167 are protective residues in the prion protein from dog and horse, two prion-resistant animals.

Jonatan Sanchez-Garcia, Pedro Fernandez-Funez

Open access · hybridAbstract read
In one paragraph

Article in Neurobiology of disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. First Report of Polymorphisms and Genetic Characteristics ofAnimals : an open access journal from MDPI · 2024
    Article
  7. Article
  8. The First Genetic Characterization of theAnimals : an open access journal from MDPI · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Intrinsic determinants of prion protein neurotoxicity inFrontiers in molecular neuroscience · 2023
    Review
  14. Article
  15. Probing the origin of prion protein misfolding via reconstruction of ancestral proteins.Protein science : a publication of the Protein Society · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jonatan Sanchez-GarciaDepartment of Biomedical Sciences, University of Minnesota Medical School, Duluth Campus, Duluth, MN 55812, USA.
Pedro Fernandez-FunezDepartment of Biomedical Sciences, University of Minnesota Medical School, Duluth Campus, Duluth, MN 55812, USA. Electronic address: pfernand@d.umn.edu.
University of Minnesota, Duluth · US

Funding

Resource Component: Acquisition, maintenance and distribution of Drosophila stocksP40OD018537 · OD · TRUSTEES OF INDIANA UNIVERSITY · PI KEVIN R COOK · 2014 to 2026
$13.5M
Mechanisms of Prion MisfoldingDP2OD002721 · OD · UNIVERSITY OF TEXAS MED BR GALVESTON · PI FERNANDEZ-FUNEZ, PEDRO · 2007 to 2010
$2.2M
Intrinsic and extrinsic factors regulating prion protein neurotoxicityR21NS096627 · NINDS · UNIVERSITY OF MINNESOTA · PI FERNANDEZ-FUNEZ, PEDRO · 2016 to 2017
$416k
NIH HHS DP2 OD002721NIH HHS P40 OD018537NINDS NIH HHS R21 NS096627
6 · The paper itself

Abstract

Prion diseases are fatal neurodegenerative diseases caused by misfolding of the prion protein (PrP). These conditions affect humans and animals, including endemic forms in sheep and deer. Bovine, rodents, and many zoo mammals also developed prion diseases during the "mad-cow" epidemic in the 1980's. Interestingly, rabbits, horses, and dogs show unusual resistance to prion diseases, suggesting that specific sequence changes in the corresponding endogenous PrP prevents the accumulation of pathogenic conformations. In vitro misfolding assays and structural studies have identified S174, S167, and D159 as the key residues mediating the stability of rabbit, horse, and dog PrP, respectively. Here, we expressed the WT forms of rabbit, horse, and dog PrP in transgenic Drosophila and found that none of them is toxic. Replacing these key residues with the corresponding amino acids in hamster PrP showed that mutant horse (S167D) and dog (D159N) PrP are highly toxic, whereas mutant rabbit (S174 N) PrP is not. These results confirm the impact of S167 and D159 in local and long-range structural features in the globular domain of PrP that increase its stability, while suggesting the role of additional residues in the stability of rabbit PrP. Identifying these protective amino acids and the structural features that stabilize PrP can contribute to advance the field towards the development of therapies that halt or reverse the devastating effects of prion diseases.

Indexed as

Amino Acid SequenceAnimalsAnimals, Genetically ModifiedCricetinaeDogsDrosophilaFemaleHorsesHumansLocomotionMicePrion DiseasesPrion ProteinsProtein Structure, SecondaryRabbitsSpecies SpecificityPrion ProteinsAmino acid substitutionDrosophilaNeurotoxicityPrion proteinSusceptibilityTransgenics

Identifiers

PMID30010001
PMCPMC6139044
OpenAlexW2884151804

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.